Pembrolizumab-induced Pure Red Cell Aplasia Successfully Treated with Intravenous Immunoglobulin

被引：10

作者：

Isoda, Atsushi ^{[1
,2
]}

Miyazawa, Yuri ^{[1
]}

Tahara, Kenichi ^{[1
]}

Mihara, Masahiro ^{[1
]}

Saito, Akio ^{[1
]}

Matsumoto, Morio ^{[1
]}

Sawamura, Morio ^{[1
]}

机构：

[1] Natl Hosp Org Shibukawa Med Ctr, Dept Hematol, Shibukawa, Gunma, Japan

[2] Hoshi Clin, Dept Hematol, Sapporo, Hokkaido, Japan

来源：

INTERNAL MEDICINE | 2020年 / 59卷 / 16期

关键词：

pure red cell aplasia; pembrolizumab; programed cell death 1; immune-related adverse events; direct anti-globulin test; intravenous immunoglobulin; AUTOIMMUNE HEMOLYTIC-ANEMIA; IMMUNOTHERAPY; RITUXIMAB; LYMPHOMA;

D O I：

10.2169/internalmedicine.4467-20

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We herein report a 64-year-old man who was treated with pembrolizumab for relapsed Hodgkin lymphoma. After the third administration of pembrolizumab, he showed acute anemia with a positive direct antiglobulin test. Because of the markedly erythroid hypoplasia, he was diagnosed with pure red cell aplasia (PRCA) caused by pembrolizumab. He was initially treated with prednisolone, but the reticulocytes decreased after tapering prednisolone. He then received high-dose intravenous immunoglobulin (WIG) with prednisolone, and PRCA was successfully treated. Although the pathogenesis of PRCA caused by immune checkpoint inhibitors (CPIs) remains unclear, WIG treatment may be effective for some steroid-refractory CPI-induced PRCA cases.

引用

页码：2041 / 2045

页数：5

共 50 条

[21] A case of pembrolizumab-induced hemophagocytic lymphohistiocytosis successfully treated with pulse glucocorticoid therapy
Takahashi, Hidenori
Koiwa, Tomohiro
Fujita, Akira
Suzuki, Takayuki
Tagashira, Amane
Iwasaki, Yoshinobu
RESPIRATORY MEDICINE CASE REPORTS, 2020, 30
[22] Successfully Treated Heparin Induced Thrombocytopenia with Intravenous Immunoglobulin
Karem, E.
Bukamur, H. S.
Mezughi, H.
Alkhankan, E.
Shweihat, Y. R.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
[23] RIFAMPICIN INDUCED PURE RED CELL APLASIA
Ceh, Marija
ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL, 2008, 77 : I139 - I141
[24] SUCCESSFUL TREATMENT OF PURE RED CELL APLASIA IN A CHILD BY HIGH DOSE INTRAVENOUS IMMUNOGLOBULIN. 94
G C Del Vecchio
L Piacente
D De Mattia
F Schettini
Pediatric Research, 1997, 41 (5) : 762 - 762
[25] Refractory idiopathic pure red cell aplasia complicated by immune thrombocytopenia successfully treated with subcutaneous alemtuzumab
Pham, Dat C.
Guthrie, Troy H.
Villas, Bruce H.
Salazar, Elaine
AMERICAN JOURNAL OF HEMATOLOGY, 2008, 83 (07) : 603 - 603
[26] Pure Red Cell Aplasia Induced Only by Intravenous Administration of Recombinant Human Erythropoietin
Shimizu, Hiroaki
Saitoh, Takayuki
Ota, Fumie
Jimbo, Takahiro
Tsukada, Yoshito
Murakami, Hirokazu
Nojima, Yoshihisa
ACTA HAEMATOLOGICA, 2011, 126 (02) : 114 - 118
[27] Intravenous immunoglobulin for pembrolizumab-induced bullous pemphigoid-like eruption: A case report
Hoshina, Daichi
Hotta, Moeko
DERMATOLOGIC THERAPY, 2022, 35 (12)
[28] Intravenous Immunoglobulin (IVIG) Triumph: Managing Pembrolizumab-Induced Pneumonitis in the Absence of Clear Guidelines
Tebaldi, M.
Anderson, Z.
Belancourt, F.
Messina, N.
Wilson, B. C.
Patel, V.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
[29] Pure Red Cell Aplasia Induced by Atezolizumab in a Patient with Small-Cell Lung Cancer Successfully Treated with Steroid Therapy: A Case Report
Kawakado, Keita
Ito, Shunsuke
Kono, Kento
Mitarai, Yuki
Yanagawa, Takashi
Nagasaki, Makoto
CASE REPORTS IN ONCOLOGY, 2023, 16 (01): : 1592 - 1597
[30] Costs of Intravenous Immunoglobulin Therapy in Patients With Unconfirmed Parvovirus B19 Pure Red Cell Aplasia
Mouthon, Luc
Miche, Morgane
Gandre, Coralie
Montagnier-Petrissans, Catherine
Chevreul, Karine
CLINICAL INFECTIOUS DISEASES, 2015, 60 (03) : 488 - 488

← 1 2 3 4 5 →